loadpatents
name:-0.0091378688812256
name:-0.0053691864013672
name:-0.0017929077148438
Farah; Nabil Patent Filings

Farah; Nabil

Patent Applications and Registrations

Patent applications and USPTO patent grants for Farah; Nabil.The latest application filed is for "pharmaceutical composition comprising solid dispersion of bcs class ii drugs with gelucires".

Company Profile
1.6.4
  • Farah; Nabil - Sant-Priest FR
  • Farah, Nabil - Lyon FR
  • Farah; Nabil - Lyons FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical composition comprising solid dispersion of BCS class II drugs with Gelucires
Grant 10,952,966 - Farah , et al. March 23, 2
2021-03-23
Pharmaceutical Composition Comprising Solid Dispersion of BCS Class II Drugs with Gelucires
App 20170119671 - FARAH; Nabil ;   et al.
2017-05-04
Immediate-release oral pellet comprising polyglycolysed glycerides, and manufacturing process
App 20030021844 - Barthelemy, Philippe ;   et al.
2003-01-30
Process for the manufacture of a pharmaceutical composition with modified release of active principle comprising a matrix
App 20020142037 - Farah, Nabil ;   et al.
2002-10-03
Process for manufacturing tablets for the sustained release of active principle(s)
Grant 6,379,700 - Joachim , et al. April 30, 2
2002-04-30
Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix
Grant 6,375,987 - Farah , et al. April 23, 2
2002-04-23
Orally administrable composition capable of providing enhanced bioavailability when ingested
Grant 6,312,704 - Farah , et al. November 6, 2
2001-11-06
Process for manufacturing tablets for the sustained release of active principle(s)
App 20010003590 - Joachim, Joseph ;   et al.
2001-06-14
Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix
Grant 6,194,005 - Farah , et al. February 27, 2
2001-02-27
Orally administrable composition capable of providing enhanced bioavailability when ingested
Grant 6,054,136 - Farah , et al. April 25, 2
2000-04-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed